These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1150 related articles for article (PubMed ID: 1932542)

  • 1. Temporal trends in the incidence of cutaneous malignant melanoma among Caucasians in the San Francisco-Oakland MSA.
    Horn-Ross PL; Holly EA; Brown SR; Aston DA
    Cancer Causes Control; 1991 Sep; 2(5):299-305. PubMed ID: 1932542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous melanoma at Lawrence Livermore National Laboratory: comparison with rates in two San Francisco bay area counties.
    Gong G; Whittemore AS; West D; Moore DH
    Cancer Causes Control; 1992 May; 3(3):191-7. PubMed ID: 1610965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance bias and the excess risk of malignant melanoma among employees of the Lawrence Livermore National Laboratory.
    Hiatt RA; Krieger N; Sagebiel RW; Clark WH; Mihm MC
    Epidemiology; 1993 Jan; 4(1):43-7. PubMed ID: 8420580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site.
    Chen YT; Zheng T; Holford TR; Berwick M; Dubrow R
    Cancer Causes Control; 1994 Jul; 5(4):341-50. PubMed ID: 8080946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in incidence of various morphologies of malignant melanoma in Vaud and Neuchatel, Switzerland.
    Levi F; Te VC; Randimbison L; La Vecchia C
    Melanoma Res; 2005 Feb; 15(1):73-5. PubMed ID: 15714124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.
    Pruthi DK; Guilfoyle R; Nugent Z; Wiseman MC; Demers AA
    J Am Acad Dermatol; 2009 Jul; 61(1):44-50. PubMed ID: 19395122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across Canada.
    Ghazawi FM; Le M; Lagacé F; Cyr J; Alghazawi N; Zubarev A; Roy SF; Rahme E; Netchiporouk E; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
    J Cutan Med Surg; 2019; 23(4):394-412. PubMed ID: 31132871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Garbe C; Orfanos CE
    Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study.
    Ghazawi FM; Cyr J; Darwich R; Le M; Rahme E; Moreau L; Netchiporouk E; Zubarev A; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
    J Am Acad Dermatol; 2019 Feb; 80(2):448-459. PubMed ID: 30092328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review.
    Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
    Cancer; 1994 Mar; 73(6):1625-30. PubMed ID: 8156490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonal variation in the incidence of cutaneous malignant melanoma: an analysis by body site and histologic type.
    Schwartz SM; Armstrong BK; Weiss NS
    Am J Epidemiol; 1987 Jul; 126(1):104-11. PubMed ID: 3591775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma.
    Anderson WF; Pfeiffer RM; Tucker MA; Rosenberg PS
    Cancer; 2009 Sep; 115(18):4176-85. PubMed ID: 19536874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying individuals at high risk of melanoma: a practical predictor of absolute risk.
    Fears TR; Guerry D; Pfeiffer RM; Sagebiel RW; Elder DE; Halpern A; Holly EA; Hartge P; Tucker MA
    J Clin Oncol; 2006 Aug; 24(22):3590-6. PubMed ID: 16728488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Württemberg).
    Lasithiotakis K; Leiter U; Krüger-Krasagakis S; Tosca A; Garbe C
    Br J Dermatol; 2006 Jun; 154(6):1123-7. PubMed ID: 16704644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Sex-Specific Incidence of Melanoma.
    Olsen CM; Thompson JF; Pandeya N; Whiteman DC
    JAMA Dermatol; 2020 May; 156(5):553-560. PubMed ID: 32211827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant melanomas on head/neck and foot: differences in time and latitudinal trends in Norway.
    Juzeniene A; Micu E; Porojnicu AC; Moan J
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):821-7. PubMed ID: 21707773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous Melanoma in Alpine Population: Incidence Trends and Clinicopathological Profile.
    Buja A; Rugge M; De Luca G; Bovo E; Zorzi M; De Toni C; Cozzolino C; Vecchiato A; Del Fiore P; Spina R; Cinquetti S; Baldo V; Rossi CR; Mocellin S
    Curr Oncol; 2022 Mar; 29(3):2165-2173. PubMed ID: 35323375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The sun and malignant melanoma].
    Garbe C
    Hautarzt; 1992 May; 43(5):251-7. PubMed ID: 1612913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
    van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
    J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations.
    Bucchi L; Mancini S; Zamagni F; Crocetti E; Dal Maso L; Ferretti S; Baldacchini F; Giuliani O; Ravaioli A; Vattiato R; Brustolin A; Candela G; Carone S; Carrozzi G; Cavallo R; Dinaro YM; Ferrante M; Iacovacci S; Mazzoleni G; Musolino A; Rizzello RV; Serraino D; Biggeri A; Stanganelli I; Falcini F;
    J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):293-302. PubMed ID: 36181283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.